F19.180
Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.180 refers to a condition characterized by the misuse of psychoactive substances alongside the development of an anxiety disorder triggered by the substance use. This type of mental health issue involves both substance abuse and the significant emotional distress caused by the substances' effects on the brain's functioning. Recognizing and understanding this condition is essential for effective management and treatment, as it impacts both physical health and mental well-being.
Causes & Symptoms
Clinical Causes: Repeated use of psychoactive substances such as alcohol, opioids, stimulants, sedatives, or hallucinogens. Underlying mental health issues like depression or anxiety that may increase susceptibility to substance misuse. Environmental factors, including stress, peer pressure, or traumatic experiences, which can lead to substance abuse. Genetic predisposition towards addiction or mental health disorders. Use of substances as a maladaptive way to cope with psychological distress or emotional pain.
Key Symptoms: Persistent craving or desire to use specific psychoactive substances. Developing anxiety, nervousness, or panic attacks that are directly related to substance use. Restlessness or agitation when not under the influence of the substance. Difficulty controlling or reducing substance intake despite negative consequences. Physical signs of substance abuse, such as bloodshot eyes, changes in appetite, or social withdrawal. Sleep disturbances, including insomnia or hypersomnia related to substance effects. Mood swings or heightened irritability linked to fluctuations in substance levels or withdrawal.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of F19.180 involves a comprehensive clinical assessment, including a detailed medical history, mental health evaluation, and physical examination. Healthcare providers may use screening tools to identify substance use patterns and assess the presence of substance-induced anxiety symptoms. Laboratory tests, such as blood or urine analysis, can confirm the presence of psychoactive substances. A mental health professional differentiates between primary anxiety disorders and those induced by substance use, ensuring an accurate diagnosis.
Treatment Protocols: Managing this condition typically requires an integrated approach combining substance abuse treatment and mental health care. Common treatment strategies include: - **Detoxification:** Medical supervision to safely manage withdrawal symptoms. - **Psychotherapy:** Approaches like cognitive-behavioral therapy (CBT) to address underlying causes of substance use and anxiety. - **Medication:** Prescribed to reduce cravings, manage withdrawal symptoms, or alleviate anxiety, under medical supervision. - **Support groups:** Participation in community or peer support groups can foster recovery and provide emotional support. - **Lifestyle modifications:** Encouragement of healthy routines, stress management techniques, and avoidance of triggers. Effective treatment involves a personalized plan tailored to the individual's specific needs and circumstances, often requiring ongoing care and support.
Clinical Advice & FAQs
Billing Guidance
Is F19.180 a billable ICD-10 code?
Yes, F19.180 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.180?
Clinical documentation must specify the nature of Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference